| |
Between The Lines: Navigating The Uncharted Territory Of Industry-Sponsored Research
Frank Davidoff
| The first 100 words of the full text of this article appear below. |
If you want to keep a secret, put it into your "Information for Authors"; no one ever reads that stuff, goes a joke among medical journal editors. True, that section is dull and full of fussy detail. But its also where lurk the heavy-duty ethical issues such as conflict of interest that tend to bite you on the leg if ignored.
And ignore them we could not. In 1995 the report of a large, industry-supported drug trial submitted to Annals of Internal Medicine forced us to rethink our approach to handling industry-project relationships in the clinical research we published. In . . . [Full Text of this Article]
|
Forming Editorial Consensus
|
|---|

What's this?
This article has been cited by other articles:

|
 |

|
 |
 
D. L. Nordstrom
The Professionalization Of Editing
Health Aff.,
May 1, 2008;
27(3):
890 - 891.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G DuVal
Institutional ethics review of clinical study agreements
J. Med. Ethics,
February 1, 2004;
30(1):
30 - 34.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. J. Tobin
Conflicts of Interest and AJRCCM: Restating Policy and a New Form to Upload
Am. J. Respir. Crit. Care Med.,
May 1, 2003;
167(9):
1161 - 1164.
[Full Text]
[PDF]
|
 |
|
|